Xencor | GJELD



Debt Endring Dato
AbbVie USD 67.14B 3.94B 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 60.1B 299M 2024-12
Arrowhead Research USD 409.41M 16.23M 2024-12
AstraZeneca USD 30.3B 1.27B 2024-12
Biogen USD 6.3B 1.9M 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Cytokinetics USD 657.12M 1.1M 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
J&J USD 36.63B 883M 2024-12
MacroGenics USD 0 0 2024-09
Merck USD 37.11B 1.02B 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06
Xencor USD 163.61M 145.69M 2024-12



Xencor GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.